Good Health Can’t Wait.

More documents

Recommendations

Info

Good Health Can’t Wait. Dr. Reddy’s Laboratories Limited NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (All amounts in Indian Rupees millions, except share data and where otherwise stated) 2.16: OTHER OPERATING REVENUE PARTICULARS FOR THE YEAR ENDED 31 MARCH 2015 FOR THE YEAR ENDED 31 MARCH 2014 Sale of spent chemicals 521 481 Scrap sales 299 152 Miscellaneous income (a) 329 713 1,149 1,346 (a) Miscellaneous income for the year ended 31 March 2014 includes an amount of ` 415 (CAD 6.75 million) towards resolution of litigation associated with the sale of one of the Company’s generic products in North America. 2.17: OTHER INCOME PARTICULARS FOR THE YEAR ENDED 31 MARCH 2015 FOR THE YEAR ENDED 31 MARCH 2014 Interest income On fixed deposits 694 1,054 Others 360 31 Profit on sale of fixed assets, net - 24 Dividend from mutual fund units 26 - Profit on sale of current investments, net 729 213 Foreign exchange gain, net 917 354 Miscellaneous income 15 21 2,741 1,697 2.18: CHANGES IN INVENTORIES OF FINISHED GOODS, WORK-IN-PROGRESS AND STOCK-IN-TRADE PARTICULARS FOR THE YEAR ENDED 31 MARCH 2015 FOR THE YEAR ENDED 31 MARCH 2014 Opening Work-in-progress 6,690 5,638 Finished goods 8,054 5,992 Stock-in-trade 1,663 16,407 1,581 13,211 Closing Work-in-progress 6,850 6,690 Finished goods 7,594 8,054 Stock-in-trade 2,521 16,965 1,663 16,407 (558) (3,196) 2.19: EMPLOYEE BENEFITS EXPENSE PARTICULARS FOR THE YEAR ENDED 31 MARCH 2015 FOR THE YEAR ENDED 31 MARCH 2014 Salaries, wages and bonus 24,843 20,991 Contribution to provident and other funds 1,909 1,340 Staff welfare expenses 2,175 1,955 Stock compensation expense, net 519 468 29,446 24,755 190
Consolidated Financial Statements Annual Report 2014 - 15 NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (All amounts in Indian Rupees millions, except share data and where otherwise stated) 2.20: FINANCE COSTS PARTICULARS FOR THE YEAR ENDED 31 MARCH 2015 FOR THE YEAR ENDED 31 MARCH 2014 Interest on long term borrowings 439 410 Interest on other borrowings 642 1,104 (Gain) / Loss on interest rate swaps, net 10 (259) Changes in fair valuation of current investments (9) 12 1,082 1,267 2.21: OTHER EXPENSES PARTICULARS FOR THE YEAR ENDED 31 MARCH 2015 FOR THE YEAR ENDED 31 MARCH 2014 Consumption of stores, spares and other materials 4,520 3,976 Excise duty 743 562 Clinical trials and other R&D expenses 9,605 7,758 Advertisements 1,362 1,598 Commission on sales 198 177 Carriage outwards 3,124 3,047 Other selling expenses 8,891 7,826 Legal and professional 3,465 3,717 Power and fuel 3,391 3,199 Repairs and maintenance Buildings 364 203 Plant and machinery 2,238 1,987 Others 1,335 1,345 Insurance 475 499 Travel and conveyance 1,923 1,878 Rent 746 749 Rates and taxes 907 671 CSR and donations* 329 188 Provision for doubtful debts, net 168 168 Provision / (reversal of provision) for doubtful advances, net 16 (2) Non Executive Directors’ remuneration 80 80 Auditors’ remuneration (Refer note 2.29) 15 14 Loss on sale of fixed assets, net 144 - Other general expenses 2,762 2,435 46,801 42,075 * Includes an amount of ` 292 incurred during the year ended 31 March 2015 towards various Corporate Social Responsibility (CSR) activities in accordance with section 135 of the Companies Act, 2013. 191
Page 1 and 2:
ANNUAL REPORT 2014-15 Good Health C
Page 3 and 4:
Our Brand We are in the business of
Page 5 and 6:
Corporate Overview Annual Report 20
Page 7 and 8:
Page 9 and 10:
Page 11 and 12:
Page 13 and 14:
Page 15 and 16:
Page 17 and 18:
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Statutory Reports • Business Resp
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Statutory Reports • Management Di
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Statutory Reports • Corporate Gov
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Statutory Reports • Additional Sh
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Statutory Reports • Board’s Rep
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Standalone Financial Statements Ann
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141 and 142: Standalone Financial Statements Ann
Page 165 and 166: Consolidated Financial Statements A
Page 191: Consolidated Financial Statements A
Page 227 and 228: Notice Annual Report 2014 - 15 NOTI
Page 229 and 230: E-Voting Annual Report 2014 - 15 IN
Page 231: Dr. Reddy’s Laboratories Limited
Page 235 and 236: The future belongs, not to those wh
show all

Good Health Can’t Wait.

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?